Cargando…
Effects of salubrinal on development of osteoclasts and osteoblasts from bone marrow-derived cells
BACKGROUND: Osteoporosis is a skeletal disease leading to an increased risk of bone fracture. Using a mouse osteoporosis model induced by administration of a receptor activator of nuclear factor kappa-B ligand (RANKL), salubrinal was recently reported as a potential therapeutic agent. To evaluate th...
Autores principales: | Yokota, Hiroki, Hamamura, Kazunori, Chen, Andy, Dodge, Todd R, Tanjung, Nancy, Abedinpoor, Aysan, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711788/ https://www.ncbi.nlm.nih.gov/pubmed/23816340 http://dx.doi.org/10.1186/1471-2474-14-197 |
Ejemplares similares
-
Salubrinal Acts as a Dusp2 Inhibitor and Suppresses Inflammation in Anti-Collagen Antibody-Induced Arthritis
por: Hamamura, Kazunori, et al.
Publicado: (2015) -
eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice
por: Li, Jie, et al.
Publicado: (2019) -
Chondroprotective effects of Salubrinal in a mouse model of
osteoarthritis
por: Hamamura, K., et al.
Publicado: (2015) -
Distinctive Subcellular Inhibition of Cytokine-Induced Src by Salubrinal and Fluid Flow
por: Wan, Qiaoqiao, et al.
Publicado: (2014) -
A Brief Review of Bone Adaptation to Unloading
por: Zhang, Ping, et al.
Publicado: (2008)